ESR1 and breast cancer: PRL-PRLR pathway plays a complicated role in regulation of ERα-positive BC progress and engages in the crosstalk with multiple crucial factors, such as estrogen, epidermal growth factor (EGF) and insulin-like growth factor-I [31, 32].